What is Maxwell Biosciences worth?
$50.9Mlast known valuation
Maxwell Biosciences last raised $10.9M in its Early Stage VC (Oct 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Maxwell Biosciences
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2021 | Early Stage VC | $10.9M | ▮ | ▮ |
How Maxwell Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Maxwell Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Maxwell Biosciences worth?
- Maxwell Biosciences's last known valuation is $50.9M.
- How much has Maxwell Biosciences raised?
- Maxwell Biosciences has raised $35.5M in total funding across 1 recorded rounds.
- When did Maxwell Biosciences last raise?
- Maxwell Biosciences last raised in Oct 2021 (Early Stage VC), raising $10.9M.